Report cover image

Global Human Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 195 Pages
SKU # APRC20355534

Description

Summary

According to APO Research, The global Human Blood Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Human Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human Blood Products include Biotest, BPL, CSL, Grifols, Kedrion, KM Biologics, LFB Group, Octapharma and Boya Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Human Blood Products, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Human Blood Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Human Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Blood Products revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Human Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Human Blood Products revenue, projected growth trends, production technology, application and end-user industry.

Human Blood Products Segment by Company

Biotest
BPL
CSL
Grifols
Kedrion
KM Biologics
LFB Group
Octapharma
Boya Bio
Hualan Bio
Nanyue Bio
RAAS
Shuanglin Bio
CBPO
Tiantan Bio
Weiguang Bio
Takeda
Yuanda Shuyang
Human Blood Products Segment by Type

Immune Globulin
Coagulation Factor
Albumin
Other
Human Blood Products Segment by Application

Hospital
Retail Pharmacy
Other
Human Blood Products Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Blood Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Blood Products industry.
Chapter 3: Detailed analysis of Human Blood Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Blood Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Human Blood Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Global Human Blood Products Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Market Growth Prospects
1.5 Global Human Blood Products Growth Trends by Region
1.5.1 Global Human Blood Products Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Human Blood Products Market Size by Region (2020-2025)
1.5.3 Human Blood Products Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Human Blood Products Market Dynamics
2.1 Human Blood Products Industry Trends
2.2 Human Blood Products Industry Drivers
2.3 Human Blood Products Industry Opportunities and Challenges
2.4 Human Blood Products Industry Restraints
3 Competitive Landscape by Company
3.1 Global Human Blood Products Revenue by Company (2020-2025)
3.2 Global Human Blood Products Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Human Blood Products Key Company Head office and Area Served
3.4 Global Human Blood Products Company, Product Type & Application
3.5 Global Human Blood Products Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Human Blood Products Market CR5 and HHI
3.6.2 Global Top 5 and 10 Human Blood Products Players Market Share by Revenue in 2024
3.6.3 2024 Human Blood Products Tier 1, Tier 2, and Tier 3
4 Human Blood Products Market by Type
4.1 Global Human Blood Products Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Human Blood Products Market Size by Type (2020-2031)
4.3 Global Human Blood Products Market Size Share by Type (2020-2031)
5 Human Blood Products Market by Application
5.1 Global Human Blood Products Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Human Blood Products Market Size by Application (2020-2031)
5.3 Global Human Blood Products Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Biotest
6.1.1 Biotest Comapny Information
6.1.2 Biotest Business Overview
6.1.3 Biotest Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Biotest Human Blood Products Product Portfolio
6.1.5 Biotest Recent Developments
6.2 BPL
6.2.1 BPL Comapny Information
6.2.2 BPL Business Overview
6.2.3 BPL Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 BPL Human Blood Products Product Portfolio
6.2.5 BPL Recent Developments
6.3 CSL
6.3.1 CSL Comapny Information
6.3.2 CSL Business Overview
6.3.3 CSL Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 CSL Human Blood Products Product Portfolio
6.3.5 CSL Recent Developments
6.4 Grifols
6.4.1 Grifols Comapny Information
6.4.2 Grifols Business Overview
6.4.3 Grifols Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Grifols Human Blood Products Product Portfolio
6.4.5 Grifols Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Kedrion Human Blood Products Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 KM Biologics
6.6.1 KM Biologics Comapny Information
6.6.2 KM Biologics Business Overview
6.6.3 KM Biologics Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 KM Biologics Human Blood Products Product Portfolio
6.6.5 KM Biologics Recent Developments
6.7 LFB Group
6.7.1 LFB Group Comapny Information
6.7.2 LFB Group Business Overview
6.7.3 LFB Group Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 LFB Group Human Blood Products Product Portfolio
6.7.5 LFB Group Recent Developments
6.8 Octapharma
6.8.1 Octapharma Comapny Information
6.8.2 Octapharma Business Overview
6.8.3 Octapharma Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Octapharma Human Blood Products Product Portfolio
6.8.5 Octapharma Recent Developments
6.9 Boya Bio
6.9.1 Boya Bio Comapny Information
6.9.2 Boya Bio Business Overview
6.9.3 Boya Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Boya Bio Human Blood Products Product Portfolio
6.9.5 Boya Bio Recent Developments
6.10 Hualan Bio
6.10.1 Hualan Bio Comapny Information
6.10.2 Hualan Bio Business Overview
6.10.3 Hualan Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Hualan Bio Human Blood Products Product Portfolio
6.10.5 Hualan Bio Recent Developments
6.11 Nanyue Bio
6.11.1 Nanyue Bio Comapny Information
6.11.2 Nanyue Bio Business Overview
6.11.3 Nanyue Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.11.4 Nanyue Bio Human Blood Products Product Portfolio
6.11.5 Nanyue Bio Recent Developments
6.12 RAAS
6.12.1 RAAS Comapny Information
6.12.2 RAAS Business Overview
6.12.3 RAAS Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.12.4 RAAS Human Blood Products Product Portfolio
6.12.5 RAAS Recent Developments
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Comapny Information
6.13.2 Shuanglin Bio Business Overview
6.13.3 Shuanglin Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.13.4 Shuanglin Bio Human Blood Products Product Portfolio
6.13.5 Shuanglin Bio Recent Developments
6.14 CBPO
6.14.1 CBPO Comapny Information
6.14.2 CBPO Business Overview
6.14.3 CBPO Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.14.4 CBPO Human Blood Products Product Portfolio
6.14.5 CBPO Recent Developments
6.15 Tiantan Bio
6.15.1 Tiantan Bio Comapny Information
6.15.2 Tiantan Bio Business Overview
6.15.3 Tiantan Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.15.4 Tiantan Bio Human Blood Products Product Portfolio
6.15.5 Tiantan Bio Recent Developments
6.16 Weiguang Bio
6.16.1 Weiguang Bio Comapny Information
6.16.2 Weiguang Bio Business Overview
6.16.3 Weiguang Bio Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.16.4 Weiguang Bio Human Blood Products Product Portfolio
6.16.5 Weiguang Bio Recent Developments
6.17 Takeda
6.17.1 Takeda Comapny Information
6.17.2 Takeda Business Overview
6.17.3 Takeda Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.17.4 Takeda Human Blood Products Product Portfolio
6.17.5 Takeda Recent Developments
6.18 Yuanda Shuyang
6.18.1 Yuanda Shuyang Comapny Information
6.18.2 Yuanda Shuyang Business Overview
6.18.3 Yuanda Shuyang Human Blood Products Revenue and Gross Margin (US$ Million) & (2020-2025)
6.18.4 Yuanda Shuyang Human Blood Products Product Portfolio
6.18.5 Yuanda Shuyang Recent Developments
7 North America
7.1 North America Human Blood Products Market Size (2020-2031)
7.2 North America Human Blood Products Market Size by Type
7.2.1 North America Human Blood Products Market Size by Type (2020-2025)
7.2.2 North America Human Blood Products Market Size by Type (2026-2031)
7.2.3 North America Human Blood Products Market Share by Type (2020-2031)
7.3 North America Human Blood Products Market Size by Application
7.3.1 North America Human Blood Products Market Size by Application (2020-2025)
7.3.2 North America Human Blood Products Market Size by Application (2026-2031)
7.3.3 North America Human Blood Products Market Share by Application (2020-2031)
7.4 North America Human Blood Products Market Size by Country
7.4.1 North America Human Blood Products Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Human Blood Products Market Size by Country (2020-2025)
7.4.3 North America Human Blood Products Market Size by Country (2026-2031)
7.4.4 North America Human Blood Products Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Human Blood Products Market Size (2020-2031)
8.2 Europe Human Blood Products Market Size by Type
8.2.1 Europe Human Blood Products Market Size by Type (2020-2025)
8.2.2 Europe Human Blood Products Market Size by Type (2026-2031)
8.2.3 Europe Human Blood Products Market Share by Type (2020-2031)
8.3 Europe Human Blood Products Market Size by Application
8.3.1 Europe Human Blood Products Market Size by Application (2020-2025)
8.3.2 Europe Human Blood Products Market Size by Application (2026-2031)
8.3.3 Europe Human Blood Products Market Share by Application (2020-2031)
8.4 Europe Human Blood Products Market Size by Country
8.4.1 Europe Human Blood Products Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Human Blood Products Market Size by Country (2020-2025)
8.4.3 Europe Human Blood Products Market Size by Country (2026-2031)
8.4.4 Europe Human Blood Products Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Human Blood Products Market Size (2020-2031)
9.2 China Human Blood Products Market Size by Type
9.2.1 China Human Blood Products Market Size by Type (2020-2025)
9.2.2 China Human Blood Products Market Size by Type (2026-2031)
9.2.3 China Human Blood Products Market Share by Type (2020-2031)
9.3 China Human Blood Products Market Size by Application
9.3.1 China Human Blood Products Market Size by Application (2020-2025)
9.3.2 China Human Blood Products Market Size by Application (2026-2031)
9.3.3 China Human Blood Products Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Human Blood Products Market Size (2020-2031)
10.2 Asia Human Blood Products Market Size by Type
10.2.1 Asia Human Blood Products Market Size by Type (2020-2025)
10.2.2 Asia Human Blood Products Market Size by Type (2026-2031)
10.2.3 Asia Human Blood Products Market Share by Type (2020-2031)
10.3 Asia Human Blood Products Market Size by Application
10.3.1 Asia Human Blood Products Market Size by Application (2020-2025)
10.3.2 Asia Human Blood Products Market Size by Application (2026-2031)
10.3.3 Asia Human Blood Products Market Share by Application (2020-2031)
10.4 Asia Human Blood Products Market Size by Country
10.4.1 Asia Human Blood Products Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Human Blood Products Market Size by Country (2020-2025)
10.4.3 Asia Human Blood Products Market Size by Country (2026-2031)
10.4.4 Asia Human Blood Products Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Human Blood Products Market Size (2020-2031)
11.2 South America, Middle East & Africa Human Blood Products Market Size by Type
11.2.1 South America, Middle East & Africa Human Blood Products Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Human Blood Products Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Human Blood Products Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Human Blood Products Market Size by Application
11.3.1 South America, Middle East & Africa Human Blood Products Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Human Blood Products Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Human Blood Products Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Human Blood Products Market Size by Country
11.4.1 South America, Middle East & Africa Human Blood Products Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Human Blood Products Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Human Blood Products Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Human Blood Products Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.